Approval · Notice of Compliance 8349 · 2006
INDAPAMIDE: Notice of Compliance 8349
Issued October 24, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8349
- Date
- October 24, 2006
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Diuretic / antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INDAPAMIDE | 02286963 | — |
| INDAPAMIDE | 02286971 | — |
Medicinal ingredients
- INDAPAMIDE HEMIHYDRATE 1.25 MG per TAB
- INDAPAMIDE HEMIHYDRATE 2.5 MG per TAB